Biotin-thiamine-responsive basal ganglia disease: A case report
- PMID: 35003475
- PMCID: PMC8717433
- DOI: 10.1016/j.radcr.2021.12.029
Biotin-thiamine-responsive basal ganglia disease: A case report
Erratum in
-
Erratum regarding missing patient consent statements in previously published articles.Radiol Case Rep. 2023 Jan 24;18(3):1389-1390. doi: 10.1016/j.radcr.2023.01.014. eCollection 2023 Mar. Radiol Case Rep. 2023. PMID: 36818993 Free PMC article.
Abstract
Biotin-Thiamine-Responsive Basal Ganglia Disease is an extremely rare autosomal recessive neurometabolic disorder characterized by recurrent waxing and waning episodes of subacute encephalopathy and seizures. High dose biotin and thiamine administration has been shown to improve symptoms within days, and the symptoms may reappear rapidly if supplementation is discontinued. Here we present a case of a 20-year-old male with classical clinical and imaging findings of Biotin-Thiamine-Responsive Basal Ganglia Disease, with a 12-year delay in diagnosis, finally diagnosed after presenting at our institution based on imaging and subsequent reexamination of exome sequencing. In this report, we review the classic imaging findings in this disease and examine why making the diagnosis can be extremely challenging due to its wide differential. Both clinically and radiographically, this condition demonstrates significant overlap with a vast array of disease entities, ranging from viral or autoimmune encephalitis to metabolic disorders. Finally, we discuss the various negative prognostic predictors described in the literature, several of which were observed in this patient's clinical course.
Keywords: Basal ganglia; Biotin-thiamine-responsive basal ganglia disease; Neurometabolic disorder; Seizure disorder; Thiamine transporter-2 gene.
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures
References
-
- Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai MT, Al Shalaan H, et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis. 2013;8:83. doi: 10.1186/1750-1172-8-83. Epub 2013/06/08PubMed PMID: 23742248PubMed Central PMCIDPMCPMC3691666. - DOI - PMC - PubMed
-
- Algahtani H, Ghamdi S, Shirah B, Alharbi B, Algahtani R, Bazaid A. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment. Neurol Res. 2017;39(2):117–125. doi: 10.1080/01616412.2016.1263176. Epub 2016/12/03PubMed PMID: 27905264. - DOI - PubMed
-
- Ozand PT, Gascon GG, Al Essa M, Joshi S, Al Jishi E, Bakheet S, et al. Biotin-responsive basal ganglia disease: a novel entity. Brain. 1998;121(7):1267–1279. - PubMed
